{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:07:08Z","timestamp":1784387228617,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Visio Foundation","award":["Visio Foundation"],"award-info":[{"award-number":["Visio Foundation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Little is known about the utilization of low vision services (LVS) in Germany. To understand which persons and how often these services would be utilized, this study aimed to investigate low vision aids (LVAs) provision in an urban setting and to describe user characteristics and trends in their characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective study based on a population-based healthcare claims database in Cologne (N\u2009=\u2009~\u2009500,000), Germany. The study population comprised individuals, who were continuously insured at four large statutory health insurers and who redeemed a prescription for visual aids or aids for blindness between January 2014 and December 2017. We examined their socio-demographic and clinical characteristics. Trends in characteristics were examined with logistic and linear regression models over time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Out of ~\u2009500,000 persons, 781 unique individuals (~\u20090.2%) redeemed an LVA prescription. They were mainly female (68.7%), 60 years or older (75.3%) and had macular degeneration (50.6%) and\/or glaucoma (25.9%). In the working-age subgroup, 33.8% were employed. Visual aids were most often prescribed (74.1%) and of all types of LVAs, individuals most commonly redeemed a prescription for magnifiers (35.8%), screen readers (34.3%) and\/or canes (17.1%). Of the entire study population, 75.4% received their prescription from an ophthalmologist, 5.3% from a general practitioner and 7.1% from other medical specialists. Significant trends in characteristics of individuals who redeemed an LVA prescription were not found.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Between 2014 and 2017, 781 individuals in Cologne redeemed an LVA prescription. They had characteristics which mostly can be explained by the epidemiology of VI. Results indicate that individuals that redeemed LVAs have a magnification requirement of \u2265\u20091.5-fold and \u2265\u20096-fold. Furthermore, next to ophthalmologists, general practitioners and other medical specialists seem to play a role in LVA provision as well, which should be taken into account by policy makers when planning interventions for increasing LVS provision. Our findings provide a starting point to examine LVS provision in Germany.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00417-024-06541-7","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T10:02:06Z","timestamp":1718704926000},"page":"3711-3723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low vision aids provision in an urban setting in Germany between 2014 and 2017: a regional population based study with healthcare claims data"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2816-0156","authenticated-orcid":false,"given":"M. L.","family":"Stolwijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. L.","family":"van der Pas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W.R.","family":"Twisk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. M.A.","family":"van Nispen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. H.M.B.","family":"van Rens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"issue":"2","key":"6541_CR1","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"R Bourne","year":"2021","unstructured":"Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S et al (2021) Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of Disease Study. Lancet Glob Health 9(2):e130\u2013e43. https:\/\/doi.org\/10.1016\/S2214-109X(20)30425-3","journal-title":"Lancet Glob Health"},{"issue":"9","key":"6541_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1359\/JBMR.040504","volume":"19","author":"MR de Boer","year":"2004","unstructured":"de Boer MR, Pluijm SM, Lips P, Moll AC, Volker-Dieben HJ, Deeg DJ, van Rens GH (2004) Different aspects of visual impairment as risk factors for falls and fractures in older men and women. J Bone Min Res 19(9):1539\u20131547. https:\/\/doi.org\/10.1359\/JBMR.040504","journal-title":"J Bone Min Res"},{"issue":"8","key":"6541_CR3","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s11136-011-0061-y","volume":"21","author":"GI Kempen","year":"2012","unstructured":"Kempen GI, Ballemans J, Ranchor AV, van Rens GH, Zijlstra GA (2012) The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services. Qual Life Res 21(8):1405\u20131411. https:\/\/doi.org\/10.1007\/s11136-011-0061-y","journal-title":"Qual Life Res"},{"issue":"4","key":"6541_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11136-014-0835-0","volume":"24","author":"HP van der Aa","year":"2015","unstructured":"van der Aa HP, Hoeben M, Rainey L, van Rens GH, Vreeken HL, van Nispen RM (2015) Why visually impaired older adults often do not receive mental health services: the patient\u2019s perspective. Qual Life Res 24(4):969\u2013978. https:\/\/doi.org\/10.1007\/s11136-014-0835-0","journal-title":"Qual Life Res"},{"issue":"1","key":"6541_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/aos.12896","volume":"94","author":"RM van Nispen","year":"2016","unstructured":"van Nispen RM, Vreeken HL, Comijs HC, Deeg DJ, van Rens GH (2016) Role of vision loss, functional limitations and the supporting network in depression in a general population. Acta Ophthalmol 94(1):76\u201382. https:\/\/doi.org\/10.1111\/aos.12896","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"6541_CR6","doi-asserted-by":"publisher","first-page":"e003471","DOI":"10.1136\/bmjopen-2013-003471","volume":"3","author":"J K\u00f6berlein","year":"2013","unstructured":"K\u00f6berlein J, Beifus K, Schaffert C, Finger RP (2013) The economic burden of visual impairment and blindness: a systematic review. BMJ open 3(11):e003471. https:\/\/doi.org\/10.1136\/bmjopen-2013-003471","journal-title":"BMJ open"},{"issue":"8","key":"6541_CR7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/bjo.2010.194712","volume":"95","author":"RP Finger","year":"2011","unstructured":"Finger RP, Fimmers R, Holz FG, Scholl HPN (2011) Prevalence and causes of registered blindness in the largest federal state of Germany. Br J Ophthalmol 95(8):1061\u20131067. https:\/\/doi.org\/10.1136\/bjo.2010.194712","journal-title":"Br J Ophthalmol"},{"key":"6541_CR8","unstructured":"Federal Statistical Office Current population of Germany 2024 [cited 2024 Apr 11]. https:\/\/www.destatis.de\/EN\/Themes\/Society-Environment\/Population\/Current-Population\/_node.html"},{"issue":"27\u201328","key":"6541_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3238\/arztebl.2012.0484","volume":"109","author":"RP Finger","year":"2012","unstructured":"Finger RP, Bertram B, Wolfram C, Holz FG (2012) Blindness and visual impairment in Germany: a slight fall in prevalence. Dtsch Arztebl Int 109(27\u201328):484\u2013489. https:\/\/doi.org\/10.3238\/arztebl.2012.0484","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"6541_CR10","first-page":"267","volume":"39","author":"B Bertram","year":"2005","unstructured":"Bertram B (2005) Blindheit Und Sehbehinderung in Deutschland: Ursachen Und H\u00e4ufigkeit [Blindness and visual impairment in Germany: causes and prevalence]. Der Augenarzt 39(6):267\u2013268","journal-title":"Der Augenarzt"},{"issue":"9","key":"6541_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00347-006-1411-y","volume":"103","author":"C Knauer","year":"2006","unstructured":"Knauer C, Pfeiffer N (2006) Erblindung in Deutschland \u2013 heute und 2030 [Blindness in Germany - today and 2030]. Der Ophthalmologe 103(9):735\u2013741. https:\/\/doi.org\/10.1007\/s00347-006-1411-y","journal-title":"Der Ophthalmologe"},{"key":"6541_CR12","doi-asserted-by":"publisher","unstructured":"van Nispen RMA, Virgili G, Hoeben M, Langelaan M, Klevering J, Keunen JEE, van Rens G Low vision rehabilitation for better quality of life in visually impaired adults. Cochrane Database Syst Rev. 2020(1). https:\/\/doi.org\/10.1002\/14651858.CD006543.pub2","DOI":"10.1002\/14651858.CD006543.pub2"},{"key":"6541_CR13","doi-asserted-by":"publisher","unstructured":"Pfau N, Kern AO, Wolfram C, Kalckl\u00f6sch M, Pr\u00fctz F Blindheit und Sehbehinderung [Blindness and visual impairment]2017. https:\/\/doi.org\/10.17886\/rki-gbe-2017-002","DOI":"10.17886\/rki-gbe-2017-002"},{"key":"6541_CR14","doi-asserted-by":"crossref","unstructured":"Maritzen A, Kamps N (2013) Rehabilitation Bei Sehbehinderung Und Blindheit [Rehabilitation for visual impairment and blindness]. Springer-","DOI":"10.1007\/978-3-642-29869-1"},{"key":"6541_CR15","unstructured":"Heil C (2017) Psychotherapeutische Arbeit mit Menschen mit K\u00f6rper-und Sinnesbehinderungen [Psychotherapy for people with physical and sensory disabilities]. Psychotherapeutenjournal [Internet]. ; 16(1):[11\u2009\u2013\u20098 pp.]. https:\/\/www.psychotherapie-heil.de\/resources\/PTJ_1_2017_Heil.pdf"},{"key":"6541_CR16","unstructured":"Deutscher Blinden- und Sehbehindertenverband e.V Beratung & Reha [Counseling & Rehabilitation] 2022 [cited 2022 Mar 13]. https:\/\/www.dbsv.org\/beratung-reha.html"},{"issue":"11","key":"6541_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s00347-002-0704-z","volume":"99","author":"HJ Grein","year":"2002","unstructured":"Grein HJ (2002) [Low vision: provision of the visually handicapped with magnifying aids. II. Matching and prescription]. Ophthalmologe 99(11):884\u2013900. https:\/\/doi.org\/10.1007\/s00347-002-0704-z","journal-title":"Ophthalmologe"},{"key":"6541_CR18","unstructured":"Blickpunkt Auge Ratgeber Recht f\u00fcr blinde und sehbehinderte Menschen [Legal guide for blind and visually impaired people] 2021 [cited 2022 Mar 13]. https:\/\/www.dbsv.org\/files\/ueber-dbsv\/publikationen\/broschueren\/Ratgeber_Recht_barrierefrei.pdf"},{"key":"6541_CR19","doi-asserted-by":"publisher","unstructured":"Lam N, Leat SJ (2015) Reprint of: Barriers to accessing low-vision care: the patient\u2019s perspective. Can J Ophthalmol 50(Suppl 1). https:\/\/doi.org\/10.1016\/j.jcjo.2015.04.007. :S34-9","DOI":"10.1016\/j.jcjo.2015.04.007"},{"issue":"2","key":"6541_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1444-0938.2010.00556.x","volume":"94","author":"AI Matti","year":"2011","unstructured":"Matti AI, Pesudovs K, Daly A, Brown M, Chen CS (2011) Access to low-vision rehabilitation services: barriers and enablers. Clin Exp Optom 94(2):181\u2013186. https:\/\/doi.org\/10.1111\/j.1444-0938.2010.00556.x","journal-title":"Clin Exp Optom"},{"issue":"7","key":"6541_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/ijg.0000000000000985","volume":"27","author":"MA Kaleem","year":"2018","unstructured":"Kaleem MA, West SK, Im L, Swenor BK (2018) Referral to Low Vision Services for Glaucoma patients: Referral Criteria and barriers. J Glaucoma 27(7):653\u2013655. https:\/\/doi.org\/10.1097\/ijg.0000000000000985","journal-title":"J Glaucoma"},{"key":"6541_CR22","doi-asserted-by":"publisher","unstructured":"Goldstein JE, Guo X, Boland MV, Swenor BK (2020) Low Vision Care - Out of Site. Out Mind Ophthalmic Epidemiol 1\u20137. https:\/\/doi.org\/10.1080\/09286586.2020.1717546","DOI":"10.1080\/09286586.2020.1717546"},{"issue":"6","key":"6541_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1442-9071.2008.01830.x","volume":"36","author":"PM O\u2019Connor","year":"2008","unstructured":"O\u2019Connor PM, Mu LC, Keeffe JE (2008) Access and utilization of a new low-vision rehabilitation service. Clin Exp Optom 36(6):547\u2013552. https:\/\/doi.org\/10.1111\/j.1442-9071.2008.01830.x","journal-title":"Clin Exp Optom"},{"issue":"0","key":"6541_CR24","doi-asserted-by":"publisher","first-page":"030802261882159","DOI":"10.1177\/0308022618821591","volume":"0","author":"J Kaldenberg","year":"2019","unstructured":"Kaldenberg J (2019) Low vision rehabilitation services: perceived barriers and facilitators to access for older adults with visual impairment. Br J Occup Ther 0(0):0308022618821591. https:\/\/doi.org\/10.1177\/0308022618821591","journal-title":"Br J Occup Ther"},{"issue":"18","key":"6541_CR25","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1002\/cam4.3333","volume":"9","author":"M Cuypers","year":"2020","unstructured":"Cuypers M, Tobi H, Huijsmans CAA, van Gerwen L, Ten Hove M, van Weel C et al (2020) Disparities in cancer-related healthcare among people with intellectual disabilities: a population-based cohort study with health insurance claims data. Cancer Med 9(18):6888\u20136895. https:\/\/doi.org\/10.1002\/cam4.3333","journal-title":"Cancer Med"},{"issue":"1","key":"6541_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12913-022-07573-7","volume":"22","author":"D Stelzer","year":"2022","unstructured":"Stelzer D, Graf E, K\u00f6ster I, Ihle P, G\u00fcnster C, Dr\u00f6ge P et al (2022) Assessing the effect of a regional integrated care model over ten years using quality indicators based on claims data \u2013 the basic statistical methodology of the INTEGRAL project. BMC Health Serv Res 22(1):247. https:\/\/doi.org\/10.1186\/s12913-022-07573-7","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"6541_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jcjo.2018.04.024","volume":"54","author":"A Basilious","year":"2019","unstructured":"Basilious A, Basilious A, Mao A, Hutnik CML (2019) Trends in low vision care provided by ophthalmologists in Ontario between 2009 and 2015. Can J Ophthalmol 54(2):229\u2013236. https:\/\/doi.org\/10.1016\/j.jcjo.2018.04.024","journal-title":"Can J Ophthalmol"},{"issue":"8","key":"6541_CR28","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1111\/opo.12982","volume":"62","author":"ML Stolwijk","year":"2021","unstructured":"Stolwijk ML, Van Nispen RMA, van Rens GHMB (2021) Characteristics and healthcare utilization among patients of low vision services: a retrospective population-based descriptive study with healthcare claims. Invest Ophthalmol Vis Sci 62(8):3597. https:\/\/doi.org\/10.1111\/opo.12982","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"6541_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10654-019-00500-x","volume":"34","author":"W Hoffmann","year":"2019","unstructured":"Hoffmann W, Latza U, Baumeister SE, Br\u00fcnger M, Buttmann-Schweiger N, Hardt J et al (2019) Guidelines and recommendations for ensuring good epidemiological practice (GEP): a guideline developed by the German Society for Epidemiology. Eur J Epidemiol 34(3):301\u2013317. https:\/\/doi.org\/10.1007\/s10654-019-00500-x","journal-title":"Eur J Epidemiol"},{"key":"6541_CR30","unstructured":"Working Group for the Collection and Use of Secondary Data (AGENS) of the German Society for Social Medicine and Prevention (DGSMP) and the German Society for Epidemiology (DGEpi) Good Practice in Secondary Data Analysis (GPS) 2014 [cited 2023 Jan 20]. https:\/\/www.dgepi.de\/assets\/Leitlinien-und-Empfehlungen\/GPS_revision2-final_august2014.pdf"},{"issue":"10097","key":"6541_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0140-6736(17)31280-1","volume":"390","author":"R Busse","year":"2017","unstructured":"Busse R, Bl\u00fcmel M, Knieps F, B\u00e4rnighausen T (2017) Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet 390(10097):882\u2013897. https:\/\/doi.org\/10.1016\/S0140-6736(17)31280-1","journal-title":"Lancet"},{"key":"#cr-split#-6541_CR32.1","unstructured":"European Observatory on Health Systems and, Policies, Bl\u00fcmel M, Spranger A, Achstetter K, Maresso A, Busse R (2020) Germany: health system review. Copenhagen: World Health Organization. Regional Office for Europe"},{"key":"#cr-split#-6541_CR32.2","unstructured":"[cited 2022 Mar 13]. https:\/\/apps.who.int\/iris\/handle\/10665\/341674"},{"issue":"06","key":"6541_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/a-1205-0751","volume":"83","author":"N Scholten","year":"2021","unstructured":"Scholten N, Ihle P, Pfaff H, f\u00fcr das CoRe-Net K, Albus C, Jessen J et al (2021) Nachhaltige Infrastruktur f\u00fcr die Versorgungsforschung: Der Aufbau Einer Regionalen, krankenkassen\u00fcbergreifenden GKV-Routinedatenbank. Gesundheitswesen 83(06):463\u2013469. https:\/\/doi.org\/10.1055\/a-1205-0751","journal-title":"Gesundheitswesen"},{"key":"6541_CR34","unstructured":"Spitzenverband G Hilfsmittelverzeichnis [Medical aids list] 2022 [ https:\/\/hilfsmittel.gkv-spitzenverband.de\/home\/verzeichnis\/3bed4717-5674-42cc-b5c7-7c4fa66a2f94%2F11c0894c-1178-4b74-9a1a-ecd2d8e6e6a2"},{"key":"6541_CR35","unstructured":"Bundesausschuss G (2018) -10-03.pdf Hilfsmittel-Richtlinie \u00fcber die Verordnung von Hilfsmitteln in der vertrags\u00e4rztlichen Versorgung (Hilfsmittel-Richtlinie\/HilfsM-RL) in der Neufassung vom 01.04.2021 [Guideline on the Prescription of Aids in Ambulatory Medical Care in the Revised Version of 01.04.2021] 2022 [cited 2024 Apr 25]. https:\/\/www.g-ba.de\/downloads\/62-492-1666\/HilfsM-RL_2018-07-19_iK-"},{"key":"6541_CR36","unstructured":"Bundesausschuss G Hilfsmittel-Richtlinie \u00fcber die Verordnung von Hilfsmitteln in der vertrags\u00e4rztlichen Versorgung (Hilfsmittel-Richtlinie\/HilfsM-RL) in der Neufassung vom 29.10.2014 [Guideline on the Prescription of Aids in Ambulatory Medical Care in the Revised Version of 29.10.2014] 2014 [cited 2022 Mar 25]. https:\/\/www.g-ba.de\/downloads\/62-492-934\/HilfsM-RL_2014-07-17.pdf"},{"key":"6541_CR37","doi-asserted-by":"crossref","unstructured":"Bundesausschuss G Hilfsmittel-Richtlinie \u00fcber die Verordnung von Hilfsmitteln in der vertrags\u00e4rztlichen Versorgung (Hilfsmittel-Richtlinie\/HilfsM-RL) in der Neufassung vom 24.03.2016 [Guideline on the Prescription of Aids in Ambulatory Medical Care in the Revised Version of 24.03.2016] 2016 [cited 2022 Mar 25]. https:\/\/www.g-ba.de\/downloads\/62-492-1143\/HilfsM-RL_2015-12-17_iK-2016-03-24.pdf","DOI":"10.1055\/s-0042-108140"},{"key":"6541_CR38","unstructured":"Bundesausschuss G Hilfsmittel-Richtlinie \u00fcber die Verordnung von Hilfsmitteln in der vertrags\u00e4rztlichen Versorgung (Hilfsmittel-Richtlinie\/HilfsM-RL) in der Neufassung vom 17.02.2017[Guideline on the Prescription of Aids in Ambulatory Medical Care in the Revised Version of 17.02.2017] 2017 [cited 2022 Mar 25]. https:\/\/www.g-ba.de\/downloads\/62-492-1352\/HilfsM-RL_2016-11-24_iK-2017-02-17.pdf"},{"key":"6541_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-4614-9191-0_5","volume-title":"Health Care utilization in Germany: theory, methodology, and results","author":"E Swart","year":"2014","unstructured":"Swart E (2014) Health Care Utilization Research using secondary data. In: Janssen C, Swart E, von Lengerke T (eds) Health Care utilization in Germany: theory, methodology, and results. Springer New York, New York, NY, pp 63\u201386"},{"issue":"S 02","key":"6541_CR40","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1055\/a-1701-7037","volume":"83","author":"I K\u00f6ster","year":"2021","unstructured":"K\u00f6ster I, Mehl C, Siegel A, Graf E, Stelzer D, Farin-Glattacker E et al (2021) [Correction: operationalization of Quality indicators with Routine Data using the Example of the Evaluation of Integrated Care Healthy Kinzigtal]. Gesundheitswesen 83(S 02):e58. https:\/\/doi.org\/10.1055\/a-1701-7037","journal-title":"Gesundheitswesen"},{"issue":"S 02","key":"6541_CR41","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1055\/a-1585-1735","volume":"83","author":"I K\u00f6ster","year":"2021","unstructured":"K\u00f6ster I, Mehl C, Siegel A, Graf E, Stelzer D, Farin-Glattacker E et al (2021) [Operationalization of Quality indicators with Routine Data using the Example of the Evaluation of Integrated Care Healthy Kinzigtal]. Gesundheitswesen 83(S 02):S87\u2013s96. https:\/\/doi.org\/10.1055\/a-1585-1735","journal-title":"Gesundheitswesen"},{"key":"6541_CR42","doi-asserted-by":"crossref","unstructured":"Little RJ, Rubin DB (2019) Statistical analysis with missing data. Wiley","DOI":"10.1002\/9781119482260"},{"key":"6541_CR43","unstructured":"Federal Statistical Office Statistik der schwerbehinderten Menschen 2019 [cited 2022 Mar 13]. https:\/\/www.destatis.de\/DE\/Themen\/Gesellschaft-Umwelt\/Gesundheit\/Behinderte-Menschen\/_inhalt.html"},{"issue":"11","key":"6541_CR44","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s00347-015-0062-2","volume":"112","author":"EK Altpeter","year":"2015","unstructured":"Altpeter EK, Nguyen NX (2015) [Requirements for low vision magnification aids in age-related macular degeneration: data from the T\u00fcbingen low vision clinic (comparison of 2007\u20132011 with 1999\u20132005)]. Ophthalmologe 112(11):923\u2013928. https:\/\/doi.org\/10.1007\/s00347-015-0062-2","journal-title":"Ophthalmologe"},{"issue":"6","key":"6541_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00347-007-1651-5","volume":"105","author":"NX Nguyen","year":"2008","unstructured":"Nguyen NX, Weismann M, Trauzettel-Klosinski S (2008) [Spectrum of ophthalmologic and social rehabilitation at the T\u00fcbinger Low-Vision Clinic: a retrospective analysis for 1999\u20132005]. Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft 105(6):563\u2013569. https:\/\/doi.org\/10.1007\/s00347-007-1651-5","journal-title":"Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft"},{"issue":"7","key":"6541_CR46","doi-asserted-by":"publisher","first-page":"e102149","DOI":"10.1371\/journal.pone.0102149","volume":"9","author":"C Violan","year":"2014","unstructured":"Violan C, Foguet-Boreu Q, Flores-Mateo G, Salisbury C, Blom J, Freitag M et al (2014) Prevalence, determinants and patterns of Multimorbidity in Primary Care: a systematic review of Observational studies. PLoS ONE 9(7):e102149. https:\/\/doi.org\/10.1371\/journal.pone.0102149","journal-title":"PLoS ONE"},{"issue":"3","key":"6541_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3233\/WOR-172629","volume":"58","author":"YHH Goertz","year":"2017","unstructured":"Goertz YHH, Houkes I, Nijhuis FJN, Bosma H (2017) Factors associated with participation on the competitive labour market of people with visual impairments in the Netherlands. Work 58(3):251\u2013261","journal-title":"Work"},{"key":"6541_CR48","unstructured":"Knapen J, Grosscurt R, van Schelven F, Boeije H, Bastiani H, Helleman S (2020) Het werkt anders. Handreiking om de arbeidsparticipatie van mensen met een visuele of auditieve beperking te bevorderen Utrecht: Nivel"},{"issue":"1","key":"6541_CR49","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1186\/s12889-022-13077-0","volume":"22","author":"A Brunes","year":"2022","unstructured":"Brunes A, Heir T (2022) Visual impairment and employment in Norway. BMC Public Health 22(1):648. https:\/\/doi.org\/10.1186\/s12889-022-13077-0","journal-title":"BMC Public Health"},{"key":"6541_CR50","unstructured":"Federal Statistical Office Employment 2024 [cited 2024 Apr 26]. https:\/\/www.destatis.de\/EN\/Themes\/Labour\/Labour-Market\/Employment\/_node.html"},{"key":"6541_CR51","doi-asserted-by":"publisher","first-page":"1264838","DOI":"10.3389\/frhs.2024.1264838","volume":"4","author":"ML Stolwijk","year":"2024","unstructured":"Stolwijk ML, van Nispen RMA, van der Pas SL, van Rens G (2024) A retrospective big data study using healthcare insurance claims to investigate the role of comorbidities in receiving low vision services. Front Health Serv 4:1264838. https:\/\/doi.org\/10.3389\/frhs.2024.1264838","journal-title":"Front Health Serv"},{"issue":"4","key":"6541_CR52","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengoni","year":"2011","unstructured":"Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A et al (2011) Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 10(4):430\u2013439. https:\/\/doi.org\/10.1016\/j.arr.2011.03.003","journal-title":"Ageing Res Rev"},{"key":"6541_CR53","doi-asserted-by":"publisher","unstructured":"Hoffmann F, Koller D (2017) [Different regions, differently insured populations? Socio-demographic and Health-related differences between insurance funds]. Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany)). 79(1):e1\u2013e9. https:\/\/doi.org\/10.1055\/s-0035-1564074","DOI":"10.1055\/s-0035-1564074"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-024-06541-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-024-06541-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:03:12Z","timestamp":1732366992000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-024-06541-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["6541"],"URL":"https:\/\/doi.org\/10.1007\/s00417-024-06541-7","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Medical Faculty of the University of Cologne (Cologne, Germany), the health insurers included in the CoRe-Net database and the CoRe-Net Steering Board. All patient-level data within the database are anonymized for the researcher and not traceable to individuals according to the data protection regulations of the German law (\u00a7\u00a075 SGB X). To ensure privacy of individual patients, data for publication were aggregated to a minimum subgroup level of <i>n<\/i>\u2009>\u20095.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Non-financial interests"}}]}}